DK2211879T3 - Probiotiske sammensætninger samt fremgangsmåder til at indlede og understøtte vægttab - Google Patents

Probiotiske sammensætninger samt fremgangsmåder til at indlede og understøtte vægttab

Info

Publication number
DK2211879T3
DK2211879T3 DK08841594.8T DK08841594T DK2211879T3 DK 2211879 T3 DK2211879 T3 DK 2211879T3 DK 08841594 T DK08841594 T DK 08841594T DK 2211879 T3 DK2211879 T3 DK 2211879T3
Authority
DK
Denmark
Prior art keywords
initiating
methods
well
weight loss
probiotic compositions
Prior art date
Application number
DK08841594.8T
Other languages
English (en)
Inventor
Brenda E Moore
Original Assignee
Brenda E Moore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40227969&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2211879(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Brenda E Moore filed Critical Brenda E Moore
Application granted granted Critical
Publication of DK2211879T3 publication Critical patent/DK2211879T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK08841594.8T 2007-10-26 2008-10-21 Probiotiske sammensætninger samt fremgangsmåder til at indlede og understøtte vægttab DK2211879T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98284407P 2007-10-26 2007-10-26
PCT/US2008/080601 WO2009055362A1 (en) 2007-10-26 2008-10-21 Probiotic compositions and methods for inducing and supporting weight loss

Publications (1)

Publication Number Publication Date
DK2211879T3 true DK2211879T3 (da) 2014-07-21

Family

ID=40227969

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08841594.8T DK2211879T3 (da) 2007-10-26 2008-10-21 Probiotiske sammensætninger samt fremgangsmåder til at indlede og understøtte vægttab

Country Status (10)

Country Link
US (2) US9371510B2 (da)
EP (1) EP2211879B1 (da)
JP (1) JP2011500821A (da)
CN (1) CN101903032A (da)
AU (1) AU2008317000B2 (da)
CA (1) CA2740434C (da)
DK (1) DK2211879T3 (da)
ES (1) ES2473625T3 (da)
NZ (1) NZ585210A (da)
WO (1) WO2009055362A1 (da)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
EP2211879B1 (en) * 2007-10-26 2014-05-07 Brenda E. Moore Probiotic compositions and methods for inducing and supporting weight loss
EP3564357B1 (en) 2010-02-01 2022-04-06 Rebiotix, Inc. Bacteriotherapy for clostridium difficile colitis
WO2011153226A2 (en) * 2010-06-01 2011-12-08 Moore Research Enterprises Llc Cellular constituents from bacteroides, compositions thereof, and therapeutic methods employing bacteroides or cellular constituents thereof
HK1253538A1 (zh) * 2010-08-04 2019-06-21 Borody Thomas J 用於糞便菌群植入的組合物及其製備和使用方法
MX344831B (es) 2010-08-04 2017-01-04 Borody Thomas J Composiciones para el transplante floral fecal y metodos para elaborar y utilzar las mismas y dispositivos para suministrar las mismas.
HUE038600T2 (hu) * 2010-10-07 2018-10-29 California Inst Of Techn Probiotikus terápiák autizmushoz
CN101982180A (zh) * 2010-11-01 2011-03-02 西藏贝珠雅药业有限公司 一种新型的益生菌活菌***栓体
EP4129312A1 (en) 2011-03-09 2023-02-08 Regents Of The University Of Minnesota Compositions and methods for transplantation of colon microbiota
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
US20140363397A1 (en) * 2011-09-14 2014-12-11 Queen's University At Kingston Method for treatment of disorders of the gastrointestinal system
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
US9719144B2 (en) 2012-05-25 2017-08-01 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
ES2436251B1 (es) 2012-05-25 2014-10-08 Consejo Superior De Investigaciones Científicas (Csic) Bacteroides cect 7771 y su uso en la prevención y tratamiento de sobrepeso, obesidad y alteraciones metabólicas e inmunológicas.
US10220089B2 (en) 2012-08-29 2019-03-05 California Institute Of Technology Diagnosis and treatment of autism spectrum disorder
WO2014113483A1 (en) 2013-01-15 2014-07-24 Metamodix, Inc. System and method for affecting intestinal microbial flora
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
AU2015236045B2 (en) * 2014-03-25 2021-09-23 Ginkgo Bioworks, Inc. Methods and genetic systems for cell engineering
EP3202892A4 (en) * 2014-09-30 2018-03-14 Ruijin Hospital Affiliated To Shanghai Jiao Tong U Uses of bacteroides in treatment or prevention of obesity-related diseases
WO2016049827A1 (en) * 2014-09-30 2016-04-07 Bgi Shenzhen Co., Limited Use of bacteroides in prevention and treatment for coronary artery disease
CN104546935A (zh) * 2014-09-30 2015-04-29 深圳华大基因科技有限公司 多形拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
EP3012270A1 (en) * 2014-10-23 2016-04-27 Institut Gustave Roussy Products for modulating microbiota composition for improving the efficacy of a cancer treatment with an immune checkpoint blocker
EP3209692B1 (en) * 2014-10-23 2024-05-22 Institut Gustave Roussy Methods and products for modulating microbiota composition for improving the efficacy of a cancer treatment with an immune checkpoint blocker
EP3212289A4 (en) 2014-10-30 2018-05-16 California Institute of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
EP3998074A1 (en) 2014-10-30 2022-05-18 California Institute of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
ES2794125T3 (es) * 2014-12-08 2020-11-17 Gi Biome Composición farmacéutica para prevenir o tratar enfermedades metabólicas, que comprende Bacteroides acidifaciens como principio activo
SI3193901T1 (en) 2014-12-23 2018-06-29 4D Pharma Research Limited Pirin polypeptide and immune modulation
LT3065748T (lt) * 2014-12-23 2018-03-12 4D Pharma Research Limited Bacteroides thetaiotaomicron padermė ir jos panaudojimas uždegimo sumažinimui
CA2985827A1 (en) 2015-05-14 2016-11-17 Crestovo Holdings Llc Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
KR102358879B1 (ko) 2015-05-22 2022-02-08 아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 자폐 스펙트럼 장애 및 관련된 증상을 치료하는 방법
US10905726B2 (en) 2015-06-09 2021-02-02 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
BR112017026586B1 (pt) * 2015-06-09 2021-11-03 Rebiotix, Inc. Composições de terapia de restauração de microbiota (mrt) e métodos de fabricação
US10828340B2 (en) 2015-06-09 2020-11-10 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10799539B2 (en) 2015-06-09 2020-10-13 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
MA51639A (fr) 2015-06-15 2020-04-15 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PE20180242A1 (es) 2015-06-15 2018-01-31 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
DK3307288T3 (da) 2015-06-15 2019-10-07 4D Pharma Res Ltd Sammensætninger omfattende bakteriestammer
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN106389478B (zh) * 2015-07-31 2019-12-24 广州知易生物科技有限公司 脆弱拟杆菌在治疗和/或预防肥胖症或糖尿病中的应用
CN105106243A (zh) * 2015-08-03 2015-12-02 上海交通大学医学院附属瑞金医院 Bacteroides thetaiotaomicron VPI-5482在制备治疗或预防肥胖症药物中的应用
CN105030842A (zh) * 2015-08-24 2015-11-11 上海交通大学医学院附属瑞金医院 Bacteroides intestinalis DSM 17393菌株的应用
DK3209310T3 (da) 2015-11-20 2018-04-16 4D Pharma Res Ltd Sammensætninger omfattende bakteriestammer
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN106852938A (zh) * 2015-12-09 2017-06-16 深圳华大基因研究院 拟杆菌(Bacteroides)在治疗和预防肥胖相关疾病中的应用
CN105455084A (zh) * 2015-12-12 2016-04-06 关岭自治县白刺花养蜂农民专业合作社 一种白刺花蜂蜜的制备方法
US9622897B1 (en) 2016-03-03 2017-04-18 Metamodix, Inc. Pyloric anchors and methods for intestinal bypass sleeves
AU2017226831B2 (en) 2016-03-04 2018-10-04 4D Pharma Plc Compositions comprising bacterial Blautia strains for treating visceral hypersensitivity
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
JP2019523758A (ja) 2016-05-23 2019-08-29 カリフォルニア インスティチュート オブ テクノロジー 神経変性障害を治療するための腸内微生物叢の制御
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US11213549B2 (en) 2016-10-11 2022-01-04 Finch Therapeutics Holdings Llc Compositions and method for treating primary sclerosing cholangitis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
WO2018112194A1 (en) 2016-12-15 2018-06-21 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for modulating growth of a genetically modified gut bacterial cell
WO2018187464A1 (en) 2017-04-05 2018-10-11 Crestovo Holdings Llc Compositions and methods for treating diverticulitis and related disorders
CN110831606A (zh) 2017-04-05 2020-02-21 克雷斯顿沃控股公司 治疗帕金森氏病(pd)和相关疾病的组合物和方法
US10695386B2 (en) 2017-05-11 2020-06-30 Shayne K. Morris Skin microbiome colonizer formulations and methods for use
CA3097521C (en) 2017-05-15 2023-10-17 Axial Biotherapeutics, Inc. Inhibitors of microbially induced amyloid
PT3630136T (pt) 2017-05-22 2021-06-11 4D Pharma Res Ltd Composições que compreendem estirpes bacterianas
EP3630942B1 (en) 2017-05-24 2022-11-30 4D Pharma Research Limited Compositions comprising bacterial strain
US11890306B2 (en) 2017-05-26 2024-02-06 Finch Therapeutics Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
BR112019026677A2 (pt) 2017-06-14 2020-06-30 4D Pharma Research Limited composições compreendendo cepas bacterianas
EP3638271B1 (en) 2017-06-14 2020-10-14 4D Pharma Research Limited Compositions comprising bacterial strains
CN109223833A (zh) * 2017-07-10 2019-01-18 上海立龙生物科技有限公司 一种预防和改善肥胖的益生菌组合物
CA3072032A1 (en) 2017-08-07 2019-02-14 Finch Therapeutics, Inc. Compositions and methods for maintaining and restoring a healthy gut barrier
WO2019118984A2 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
US11168299B2 (en) 2018-04-11 2021-11-09 Shayne Morris Pairing probiotics and prebiotics, methods for growth and use, separately and in combination
US11291696B2 (en) 2018-04-11 2022-04-05 Shayne Morris Pairing probiotics and prebiotics, methods for growth and use, separately and in combination
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
US11559479B2 (en) 2018-07-16 2023-01-24 ProBiora Health, LLC Beverage additive
WO2020051379A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
MA53617A (fr) * 2018-09-10 2021-07-21 Riken Composition pour inhiber l'activité de la trypsine, contenant, en tant que principe actif, une bactérie appartenant au genre paraprevotella
EP3856212A1 (en) 2018-09-27 2021-08-04 Finch Therapeutics Holdings LLC Compositions and methods for treating epilepsy and related disorders
CN111714522B (zh) * 2019-03-04 2022-07-15 中国科学院微生物研究所 拟杆菌及其应用
GB201907782D0 (en) * 2019-05-31 2019-07-17 Mars Inc Method
ES2886646B2 (es) * 2020-06-17 2022-06-22 Consejo Superior Investigacion Cepa del genero bacteroides para su uso en el tratamiento y/o prevencion de trastornos alimentarios
AU2022391767A1 (en) 2021-11-22 2024-07-04 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5557520A (en) * 1978-10-26 1980-04-28 Nisshin Flour Milling Co Ltd Preparation of carcinostatic substance
DE68928665T2 (de) 1988-08-02 1998-11-12 Gastro Services Pty Ltd Behandlung von gastro-intestinalen krankheiten
AUPM823094A0 (en) 1994-09-16 1994-10-13 Goodman Fielder Limited Probiotic compositions
AUPM864894A0 (en) 1994-10-07 1994-11-03 Borody, Thomas Julius Treatment of bowel-dependent neurological disorders
US5951977A (en) 1997-10-14 1999-09-14 The United States Of America, As Represented By The Secretary Of Agriculture Competitive exclusion culture for swine
AUPP816899A0 (en) * 1999-01-14 1999-02-11 Food Technology Innovations Pty Limited Improved microbial products
US20040062757A1 (en) * 2001-06-05 2004-04-01 Finegold Sydney M. Method of testing gastrointestinal diseases associated with species of genus clostridium
JP2001346577A (ja) * 2000-06-07 2001-12-18 Katsunari Onishi ヒトラクトフェリン発現プラスミド及びこれを保有するバクテロイデス属形質転換細胞
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US20040115177A1 (en) * 2001-10-12 2004-06-17 Harris Delbert L. Probiotic compositions and methods against bacterial infection in livestock animals
GB0127916D0 (en) * 2001-11-21 2002-01-16 Rowett Res Inst Method
WO2004069156A2 (en) * 2003-01-30 2004-08-19 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
US20050239706A1 (en) 2003-10-31 2005-10-27 Washington University In St. Louis Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
WO2005060937A1 (en) 2003-12-23 2005-07-07 Chr. Hansen A/S Compressed tablets comprising viable probiotic microorganisms
GB0501540D0 (en) * 2005-01-25 2005-03-02 Univ Leeds Controlled production and delivery of biologically active agents by gut bacteria
EP1861490A4 (en) 2005-03-23 2010-11-17 Univ St Louis USE OF ARRAYS TO MODULATE NUTRIENT CAPTURE FUNCTIONS BY THE GASTROINTESTINAL MICROBIOTE
US20100233312A9 (en) * 2005-04-11 2010-09-16 The Procter & Gamble Company Compositions comprising probiotic and sweetener components
WO2007087576A2 (en) 2006-01-24 2007-08-02 The Uab Research Foundation Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases
WO2008076696A2 (en) 2006-12-18 2008-06-26 Washington University In St. Louis The gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
EP2211879B1 (en) * 2007-10-26 2014-05-07 Brenda E. Moore Probiotic compositions and methods for inducing and supporting weight loss

Also Published As

Publication number Publication date
NZ585210A (en) 2012-07-27
US20160310545A1 (en) 2016-10-27
CA2740434A1 (en) 2009-04-30
US20090110664A1 (en) 2009-04-30
CA2740434C (en) 2017-11-07
AU2008317000B2 (en) 2014-10-23
US9371510B2 (en) 2016-06-21
JP2011500821A (ja) 2011-01-06
EP2211879A1 (en) 2010-08-04
CN101903032A (zh) 2010-12-01
AU2008317000A1 (en) 2009-04-30
US10226490B2 (en) 2019-03-12
EP2211879B1 (en) 2014-05-07
ES2473625T3 (es) 2014-07-07
WO2009055362A1 (en) 2009-04-30

Similar Documents

Publication Publication Date Title
DK2211879T3 (da) Probiotiske sammensætninger samt fremgangsmåder til at indlede og understøtte vægttab
BRPI0912703A2 (pt) composições imuno-moduladoras e métodos para uso dessas
DK2272339T3 (da) Fremgangsmåder og præparater til anvendelse med geldispensere
DK3812360T3 (da) Monochlortrifluorpropen forbindelser og sammensætninger og metoder, der anvender dem
DK2152748T3 (da) Anti-Notch1-NRR-antistoffer og fremgangsmåder til anvendelse deraf
ZA201001300B (en) Antigen-asjuvant compositions and methods
DK3795573T3 (da) Bestemte triazolopyraziner, sammensætninger deraf og fremgangsmåder til anvendelse deraf
DK2337837T3 (da) Alpha-amylase-blandinger og fremgangsmåder til anvendelse heraf
DK2181057T3 (da) Fremgangsmåder til at isolere tilstødende artikler
PL2497505T3 (pl) Kompozycje i sposoby tworzenia rusztowania
DK2252633T3 (da) Anti-TrkA antistoffer og derivater deraf
DK3219815T3 (da) Fremgangsmåder og sammensætninger til at fremstille squalen under anvendelse af gær
BRPI0721469A2 (pt) Plataforma autoelevatória
PL2214656T3 (pl) Kompozycje i sposoby wzmacniania odpowiedzi immunologicznej
IL210559A0 (en) Novel compositions and methods
GB2462635B (en) Turbo-machines thrust balancer
ZA201100675B (en) Drilling platform
IL208445A0 (en) Compositions and methods for immunotherapy
IL210588A0 (en) Novel compositions and methods
GB0721291D0 (en) Methods and compositions
GB0817585D0 (en) Novel compositions and methods
DK2320739T3 (da) Farmaceutiske sammensætninger og fremgangsmåder til stabilisering af disse
DE602008001282D1 (de) Auswuchtgewicht
GB0719526D0 (en) Compositions and methods
DK2262525T3 (da) Apoaequorin-holdige sammensætninger og fremgangsmåder til anvendelse af de samme